Govt Job: For M.Pharm as Junior Associate at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab, and the distinguished medical educators of the then combined state of Punjab, who, supported by the first Prime Minister of India, Pt. Jawahar Lal Nehru, considered the institutions of scientific knowledge as temples of learning and places of pilgrimage.

Post: Junior Materiovigilance Associate

Applications are invited on a plain paper for the contractual post of Junior Materiovigilance Associate under NCC-PvPI, IPC Regional Center, Department of Pharmacology, Chandigarh-160012.

Qualification : Graduation in Biomedical Engineering / Clinical Engineering or Master’s in Pharmacy

Desirable Experience: Good knowledge of Computers

Age: Not exceeding 28 years

Pay Scale: Rs. 26,250/- per month

Nature of Job: Purely Contractual (As per GeM contract)

Interested candidates fulfilling the above conditions are required to submit their bio-data and necessary testimonials/ certificates by 18th December 2022 through email at recruitmentmanpowereplpgimer@gmail.com

The short-listed candidates will be intimated through email to attend the personal or virtual interview.

Related Posts

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

UP expands food, drug testing capacity across all 18 divisions

UP expands food, drug testing capacity across all 18 divisions

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi